ID   ADCY6_HUMAN             Reviewed;        1168 AA.
AC   O43306; Q9NR75; Q9UDB0;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   10-MAY-2017, entry version 172.
DE   RecName: Full=Adenylate cyclase type 6;
DE            EC=4.6.1.1 {ECO:0000269|PubMed:17110384, ECO:0000269|PubMed:17916776};
DE   AltName: Full=ATP pyrophosphate-lyase 6;
DE   AltName: Full=Adenylate cyclase type VI;
DE   AltName: Full=Adenylyl cyclase 6 {ECO:0000303|PubMed:17916776};
DE   AltName: Full=Ca(2+)-inhibitable adenylyl cyclase;
GN   Name=ADCY6; Synonyms=KIAA0422;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Thyroid;
RX   PubMed=10978539; DOI=10.1016/S0167-4781(00)00187-1;
RA   Wicker R., Catalan A.G., Cailleux A.-F., Starenki D., Stengel D.,
RA   Sarasin A., Suarez H.G.;
RT   "Cloning and expression of human adenylyl cyclase type VI in normal
RT   thyroid tissues.";
RL   Biochim. Biophys. Acta 1493:279-283(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII.
RT   78 new cDNA clones from brain which code for large proteins in
RT   vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1040-1103.
RX   PubMed=8476432; DOI=10.1006/bbrc.1993.1415;
RA   Hellevuo K., Yoshimura M., Kao M., Hoffman P.L., Cooper D.M.F.,
RA   Tabakoff B.;
RT   "A novel adenylyl cyclase sequence cloned from the human
RT   erythroleukemia cell line.";
RL   Biochem. Biophys. Res. Commun. 192:311-318(1993).
RN   [6]
RP   INTERACTION WITH RAF1.
RX   PubMed=15385642; DOI=10.1124/mol.66.4.;
RA   Ding Q., Gros R., Gray I.D., Taussig R., Ferguson S.S., Feldman R.D.;
RT   "Raf kinase activation of adenylyl cyclases: isoform-selective
RT   regulation.";
RL   Mol. Pharmacol. 66:921-928(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54 AND SER-576, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   VARIANT SER-674, CHARACTERIZATION OF VARIANT SER-674, CATALYTIC
RP   ACTIVITY, ENZYME REGULATION, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=17916776; DOI=10.1161/ATVBAHA.107.145557;
RA   Gros R., Van Uum S., Hutchinson-Jaffe A., Ding Q., Pickering J.G.,
RA   Hegele R.A., Feldman R.D.;
RT   "Increased enzyme activity and beta-adrenergic mediated vasodilation
RT   in subjects expressing a single-nucleotide variant of human adenylyl
RT   cyclase 6.";
RL   Arterioscler. Thromb. Vasc. Biol. 27:2657-2663(2007).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, SUBCELLULAR LOCATION,
RP   AND INTERACTION WITH GNAS; GNB1 AND GNG2.
RX   PubMed=17110384; DOI=10.1074/jbc.M607522200;
RA   Gao X., Sadana R., Dessauer C.W., Patel T.B.;
RT   "Conditional stimulation of type V and VI adenylyl cyclases by G
RT   protein betagamma subunits.";
RL   J. Biol. Chem. 282:294-302(2007).
RN   [13]
RP   INVOLVEMENT IN LCCS8, AND VARIANT LCCS8 CYS-1116.
RX   PubMed=24319099; DOI=10.1093/hmg/ddt618;
RA   Laquerriere A., Maluenda J., Camus A., Fontenas L., Dieterich K.,
RA   Nolent F., Zhou J., Monnier N., Latour P., Gentil D., Heron D.,
RA   Desguerres I., Landrieu P., Beneteau C., Delaporte B., Bellesme C.,
RA   Baumann C., Capri Y., Goldenberg A., Lyonnet S., Bonneau D.,
RA   Estournet B., Quijano-Roy S., Francannet C., Odent S.,
RA   Saint-Frison M.H., Sigaudy S., Figarella-Branger D., Gelot A.,
RA   Mussini J.M., Lacroix C., Drouin-Garraud V., Malinge M.C.,
RA   Attie-Bitach T., Bessieres B., Bonniere M., Encha-Razavi F.,
RA   Beaufrere A.M., Khung-Savatovsky S., Perez M.J., Vasiljevic A.,
RA   Mercier S., Roume J., Trestard L., Saugier-Veber P., Cordier M.P.,
RA   Layet V., Legendre M., Vigouroux-Castera A., Lunardi J., Bayes M.,
RA   Jouk P.S., Rigonnot L., Granier M., Sternberg D., Warszawski J.,
RA   Gut I., Gonzales M., Tawk M., Melki J.;
RT   "Mutations in CNTNAP1 and ADCY6 are responsible for severe
RT   arthrogryposis multiplex congenita with axoglial defects.";
RL   Hum. Mol. Genet. 23:2279-2289(2014).
CC   -!- FUNCTION: Catalyzes the formation of the signaling molecule cAMP
CC       downstream of G protein-coupled receptors (PubMed:17916776,
CC       PubMed:17110384). Functions in signaling cascades downstream of
CC       beta-adrenergic receptors in the heart and in vascular smooth
CC       muscle cells (PubMed:17916776). Functions in signaling cascades
CC       downstream of the vasopressin receptor in the kidney and has a
CC       role in renal water reabsorption. Functions in signaling cascades
CC       downstream of PTH1R and plays a role in regulating renal phosphate
CC       excretion. Functions in signaling cascades downstream of the VIP
CC       and SCT receptors in pancreas and contributes to the regulation of
CC       pancreatic amylase and fluid secretion (By similarity). Signaling
CC       mediates cAMP-dependent activation of protein kinase PKA. This
CC       promotes increased phosphorylation of various proteins, including
CC       AKT. Plays a role in regulating cardiac sarcoplasmic reticulum
CC       Ca(2+) uptake and storage, and is required for normal heart
CC       ventricular contractibility. May contribute to normal heart
CC       function (By similarity). Mediates vasodilatation after activation
CC       of beta-adrenergic receptors by isoproterenol (PubMed:17916776).
CC       Contributes to bone cell responses to mechanical stimuli (By
CC       similarity). {ECO:0000250|UniProtKB:Q01341,
CC       ECO:0000250|UniProtKB:Q03343, ECO:0000269|PubMed:17110384,
CC       ECO:0000269|PubMed:17916776}.
CC   -!- CATALYTIC ACTIVITY: ATP = 3',5'-cyclic AMP + diphosphate.
CC       {ECO:0000269|PubMed:17110384, ECO:0000269|PubMed:17916776}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15385642};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:15385642};
CC       Note=Binds 2 magnesium ions per subunit. Is also active with
CC       manganese (in vitro). {ECO:0000250|UniProtKB:P30803};
CC   -!- ENZYME REGULATION: Activated by forskolin (PubMed:17916776,
CC       PubMed:17110384). Inhibited by calcium ions, already at micromolar
CC       concentrations (By similarity). Inhibited by adenosine, AMP and
CC       their analogs (By similarity). Activated by GNAS
CC       (PubMed:17110384). Is further activated by the complex formed by
CC       GNB1 and GNG2 (PubMed:17110384). Phosphorylation by RAF1 results
CC       in its activation (By similarity). {ECO:0000250|UniProtKB:P30804,
CC       ECO:0000250|UniProtKB:Q01341, ECO:0000250|UniProtKB:Q03343,
CC       ECO:0000269|PubMed:17916776}.
CC   -!- SUBUNIT: Part of a complex containing AKAP5, ADCY5, PDE4C and PKD2
CC       (By similarity). Interacts with RAF1 (PubMed:15385642). Interacts
CC       (via cytoplasmic N-terminus) with GNAS, GNB1 and GNG2
CC       (PubMed:17110384). {ECO:0000250|UniProtKB:Q01341,
CC       ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:17110384}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17110384};
CC       Multi-pass membrane protein {ECO:0000305}. Cell projection, cilium
CC       {ECO:0000250|UniProtKB:Q01341}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43306-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43306-2; Sequence=VSP_000244;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in peripheral blood mononuclear
CC       leukocytes (at protein level) (PubMed:17916776). Detected in
CC       thyroid (PubMed:10978539). {ECO:0000269|PubMed:10978539}.
CC   -!- DOMAIN: The protein contains two modules with six transmembrane
CC       helices each; both are required for catalytic activity. Isolated
CC       N-terminal or C-terminal guanylate cyclase domains have no
CC       catalytic activity, but when they are brought together, enzyme
CC       activity is restored. The active site is at the interface of the
CC       two domains. Both contribute substrate-binding residues, but the
CC       catalytic metal ions are bound exclusively via the N-terminal
CC       guanylate cyclase domain. {ECO:0000250|UniProtKB:P26769}.
CC   -!- PTM: Phosphorylation by RAF1 increases enzyme activity.
CC       Phosphorylation by PKA at Ser-662 inhibits the GNAS-mediated
CC       increase in catalytic activity. Phosphorylation by PKC at Ser-556,
CC       Ser-662 and Thr-919 inhibits catalytic activity.
CC       {ECO:0000250|UniProtKB:Q03343}.
CC   -!- DISEASE: Lethal congenital contracture syndrome 8 (LCCS8)
CC       [MIM:616287]: A form of lethal congenital contracture syndrome, an
CC       autosomal recessive disorder characterized by degeneration of
CC       anterior horn neurons, extreme skeletal muscle atrophy and
CC       congenital non-progressive joint contractures. The contractures
CC       can involve the upper or lower limbs and/or the vertebral column,
CC       leading to various degrees of flexion or extension limitations
CC       evident at birth. LCCS8 is an axoglial form of arthrogryposis
CC       multiplex congenita, characterized by congenital distal joint
CC       contractures, reduced fetal movements, and severe motor paralysis
CC       leading to death early in the neonatal period.
CC       {ECO:0000269|PubMed:24319099}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA24852.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF250226; AAF82478.1; -; mRNA.
DR   EMBL; AB007882; BAA24852.2; ALT_INIT; mRNA.
DR   EMBL; BC064923; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS8767.1; -. [O43306-1]
DR   RefSeq; NP_056085.1; NM_015270.4. [O43306-1]
DR   RefSeq; XP_006719273.1; XM_006719210.3. [O43306-1]
DR   UniGene; Hs.525401; -.
DR   UniGene; Hs.694408; -.
DR   ProteinModelPortal; O43306; -.
DR   SMR; O43306; -.
DR   BioGrid; 106625; 19.
DR   IntAct; O43306; 7.
DR   MINT; MINT-2856766; -.
DR   STRING; 9606.ENSP00000311405; -.
DR   ChEMBL; CHEMBL2097167; -.
DR   GuidetoPHARMACOLOGY; 1283; -.
DR   iPTMnet; O43306; -.
DR   PhosphoSitePlus; O43306; -.
DR   SwissPalm; O43306; -.
DR   BioMuta; ADCY6; -.
DR   MaxQB; O43306; -.
DR   PaxDb; O43306; -.
DR   PeptideAtlas; O43306; -.
DR   PRIDE; O43306; -.
DR   Ensembl; ENST00000307885; ENSP00000311405; ENSG00000174233. [O43306-1]
DR   Ensembl; ENST00000357869; ENSP00000350536; ENSG00000174233. [O43306-2]
DR   Ensembl; ENST00000550422; ENSP00000446730; ENSG00000174233. [O43306-2]
DR   GeneID; 112; -.
DR   KEGG; hsa:112; -.
DR   UCSC; uc001rsh.5; human. [O43306-1]
DR   CTD; 112; -.
DR   DisGeNET; 112; -.
DR   GeneCards; ADCY6; -.
DR   HGNC; HGNC:237; ADCY6.
DR   HPA; CAB018365; -.
DR   MalaCards; ADCY6; -.
DR   MIM; 600294; gene.
DR   MIM; 616287; phenotype.
DR   neXtProt; NX_O43306; -.
DR   OpenTargets; ENSG00000174233; -.
DR   Orphanet; 2680; Hypomyelination neuropathy - arthrogryposis.
DR   PharmGKB; PA27; -.
DR   eggNOG; KOG3619; Eukaryota.
DR   eggNOG; COG2114; LUCA.
DR   GeneTree; ENSGT00760000119042; -.
DR   HOGENOM; HOG000006941; -.
DR   HOVERGEN; HBG050458; -.
DR   InParanoid; O43306; -.
DR   KO; K08046; -.
DR   OMA; WQDEAFI; -.
DR   OrthoDB; EOG091G05JR; -.
DR   PhylomeDB; O43306; -.
DR   TreeFam; TF313845; -.
DR   Reactome; R-HSA-163359; Glucagon signaling in metabolic regulation.
DR   Reactome; R-HSA-163615; PKA activation.
DR   Reactome; R-HSA-164378; PKA activation in glucagon signalling.
DR   Reactome; R-HSA-170660; Adenylate cyclase activating pathway.
DR   Reactome; R-HSA-170670; Adenylate cyclase inhibitory pathway.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-HSA-400042; Adrenaline,noradrenaline inhibits insulin secretion.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-418597; G alpha (z) signalling events.
DR   Reactome; R-HSA-432040; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   SIGNOR; O43306; -.
DR   GeneWiki; ADCY6; -.
DR   GenomeRNAi; 112; -.
DR   PRO; PR:O43306; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000174233; -.
DR   CleanEx; HS_ADCY6; -.
DR   ExpressionAtlas; O43306; baseline and differential.
DR   Genevisible; O43306; HS.
DR   GO; GO:0005929; C:cilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0008074; C:guanylate cyclase complex, soluble; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0004016; F:adenylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; ISS:BHF-UCL.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome.
DR   GO; GO:0034199; P:activation of protein kinase A activity; TAS:Reactome.
DR   GO; GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006171; P:cAMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0071870; P:cellular response to catecholamine stimulus; IDA:BHF-UCL.
DR   GO; GO:1904322; P:cellular response to forskolin; IDA:UniProtKB.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IDA:BHF-UCL.
DR   GO; GO:1904117; P:cellular response to vasopressin; ISS:UniProtKB.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0007212; P:dopamine receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0035811; P:negative regulation of urine volume; ISS:UniProtKB.
DR   GO; GO:0097746; P:regulation of blood vessel diameter; IMP:UniProtKB.
DR   GO; GO:0003091; P:renal water homeostasis; ISS:UniProtKB.
DR   Gene3D; 3.30.70.1230; -; 2.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR032628; AC_N.
DR   InterPro; IPR030672; Adcy.
DR   InterPro; IPR009398; Adcy_conserved_dom.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   Pfam; PF16214; AC_N; 1.
DR   Pfam; PF06327; DUF1053; 1.
DR   Pfam; PF00211; Guanylate_cyc; 2.
DR   PIRSF; PIRSF039050; Ade_cyc; 1.
DR   SMART; SM00044; CYCc; 2.
DR   SUPFAM; SSF55073; SSF55073; 2.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 2.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; cAMP biosynthesis; Cell membrane;
KW   Cell projection; Cilium; Complete proteome; Disease mutation;
KW   Glycoprotein; Lyase; Magnesium; Manganese; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix.
FT   CHAIN         1   1168       Adenylate cyclase type 6.
FT                                /FTId=PRO_0000195699.
FT   TOPO_DOM      1    151       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    152    168       Helical. {ECO:0000255}.
FT   TRANSMEM    181    197       Helical. {ECO:0000255}.
FT   TRANSMEM    214    230       Helical. {ECO:0000255}.
FT   TRANSMEM    239    255       Helical. {ECO:0000255}.
FT   TRANSMEM    259    275       Helical. {ECO:0000255}.
FT   TRANSMEM    289    305       Helical. {ECO:0000255}.
FT   TOPO_DOM    306    673       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    674    691       Helical. {ECO:0000255}.
FT   TRANSMEM    702    718       Helical. {ECO:0000255}.
FT   TRANSMEM    743    759       Helical. {ECO:0000255}.
FT   TOPO_DOM    760    819       Extracellular. {ECO:0000255}.
FT   TRANSMEM    820    836       Helical. {ECO:0000255}.
FT   TRANSMEM    839    855       Helical. {ECO:0000255}.
FT   TRANSMEM    897    913       Helical. {ECO:0000255}.
FT   TOPO_DOM    914   1168       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     384    389       ATP. {ECO:0000250|UniProtKB:P30803}.
FT   NP_BIND     426    428       ATP. {ECO:0000250|UniProtKB:P30803}.
FT   NP_BIND    1105   1107       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   NP_BIND    1112   1116       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   METAL       384    384       Magnesium 1; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL       384    384       Magnesium 2; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL       385    385       Magnesium 2; via carbonyl oxygen;
FT                                catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099}.
FT   METAL       428    428       Magnesium 1; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL       428    428       Magnesium 2; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   BINDING     472    472       ATP. {ECO:0000250|UniProtKB:P30803}.
FT   BINDING    1031   1031       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   BINDING    1152   1152       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   MOD_RES      54     54       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     556    556       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03343}.
FT   MOD_RES     576    576       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     662    662       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03343}.
FT   MOD_RES     919    919       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q03343}.
FT   CARBOHYD    793    793       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     762    814       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9455477}.
FT                                /FTId=VSP_000244.
FT   VARIANT     674    674       A -> S (no effect on basal enzyme
FT                                activity, but increased enzyme activity
FT                                upon activation via G-proteins or
FT                                forskolin; dbSNP:rs3730071).
FT                                /FTId=VAR_048249.
FT   VARIANT    1116   1116       R -> C (in LCCS8; dbSNP:rs786204798).
FT                                {ECO:0000269|PubMed:24319099}.
FT                                /FTId=VAR_073434.
SQ   SEQUENCE   1168 AA;  130615 MW;  127BB6E67F73AA61 CRC64;
     MSWFSGLLVP KVDERKTAWG ERNGQKRSRR RGTRAGGFCT PRYMSCLRDA EPPSPTPAGP
     PRCPWQDDAF IRRGGPGKGK ELGLRAVALG FEDTEVTTTA GGTAEVAPDA VPRSGRSCWR
     RLVQVFQSKQ FRSAKLERLY QRYFFQMNQS SLTLLMAVLV LLTAVLLAFH AAPARPQPAY
     VALLACAAAL FVGLMVVCNR HSFRQDSMWV VSYVVLGILA AVQVGGALAA DPRSPSAGLW
     CPVFFVYIAY TLLPIRMRAA VLSGLGLSTL HLILAWQLNR GDAFLWKQLG ANVLLFLCTN
     VIGICTHYPA EVSQRQAFQE TRGYIQARLH LQHENRQQER LLLSVLPQHV AMEMKEDINT
     KKEDMMFHKI YIQKHDNVSI LFADIEGFTS LASQCTAQEL VMTLNELFAR FDKLAAENHC
     LRIKILGDCY YCVSGLPEAR ADHAHCCVEM GVDMIEAISL VREVTGVNVN MRVGIHSGRV
     HCGVLGLRKW QFDVWSNDVT LANHMEAGGR AGRIHITRAT LQYLNGDYEV EPGRGGERNA
     YLKEQHIETF LILGASQKRK EEKAMLAKLQ RTRANSMEGL MPRWVPDRAF SRTKDSKAFR
     QMGIDDSSKD NRGTQDALNP EDEVDEFLSR AIDARSIDQL RKDHVRRFLL TFQREDLEKK
     YSRKVDPRFG AYVACALLVF CFICFIQLLI FPHSTLMLGI YASIFLLLLI TVLICAVYSC
     GSLFPKALQR LSRSIVRSRA HSTAVGIFSV LLVFTSAIAN MFTCNHTPIR SCAARMLNLT
     PADITACHLQ QLNYSLGLDA PLCEGTMPTC SFPEYFIGNM LLSLLASSVF LHISSIGKLA
     MIFVLGLIYL VLLLLGPPAT IFDNYDLLLG VHGLASSNET FDGLDCPAAG RVALKYMTPV
     ILLVFALALY LHAQQVESTA RLDFLWKLQA TGEKEEMEEL QAYNRRLLHN ILPKDVAAHF
     LARERRNDEL YYQSCECVAV MFASIANFSE FYVELEANNE GVECLRLLNE IIADFDEIIS
     EERFRQLEKI KTIGSTYMAA SGLNASTYDQ VGRSHITALA DYAMRLMEQM KHINEHSFNN
     FQMKIGLNMG PVVAGVIGAR KPQYDIWGNT VNVSSRMDST GVPDRIQVTT DLYQVLAAKG
     YQLECRGVVK VKGKGEMTTY FLNGGPSS
//
